<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00548483</url>
  </required_header>
  <id_info>
    <org_study_id>MMH-I-S-107</org_study_id>
    <nct_id>NCT00548483</nct_id>
  </id_info>
  <brief_title>Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults</brief_title>
  <official_title>Phase 2 Study of Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mackay Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The specific objectives were to determine whether high dose dexamethasone are more effective
      than low dose dexamethasone in the reduction or prevention of post-extubation airway
      obstruction among patients with a cuff leak volume (CLV) &lt; 110 mL.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Controversy currently exists regarding the effectiveness of prophylactic steroid therapy for
      patients considered at high risk for post-extubation stridor. Studies regarding the efficacy
      of prophylactic corticosteroids for intubated patients have yielded conflicting results due
      to differences in the number, dose, or type of corticosteroids administered.

      Only a limited number of prospective trials involving adults and evaluating the benefits and
      the dose of corticosteroid therapy prior to extubation have been conducted.The present study
      was conducted to evaluate the effects of prophylactic dexamethasone therapy for a subset of
      high-risk patients who had been intubated for &gt; 48 hours and who were undergoing their first
      elective extubation in an ICU setting.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2007</start_date>
  <completion_date type="Anticipated">May 2008</completion_date>
  <primary_completion_date type="Anticipated">March 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>absolute cuff leak volumes and relative cuff leak volume to tidal volume(%)(measured CLV-baseline CLV) X 100/ tidal volume)</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Airway Obstruction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexamethasone 5mg was administered every 6 hour for 1 day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexamethasone 10mg was administered every 6 hour for 1 day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexamethasone (Oradexon, Nederland)</intervention_name>
    <description>dexamethasone 5mg was administered every 6 hour for 1 day in group 1 and dexamethasone 10mg was administered every 6 hour for 1 day in group 2</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients were &gt; 18 years of age and met the following weaning criteria:

          1. Temperature ≤ 38°C for &gt; 8 hours,

          2. Discontinuous use of sedatives,

          3. Heart rate ≥ 70 and ≤ 130 /min,

          4. Systolic blood pressure (SBP) ≥ 80 mm Hg in the absence of vasopressors,

          5. Fraction of inspired oxygen (FiO2) ≤ 0.6, PaO2 ≥ 60, and partial pressure of oxygen
             (PaO2)/FiO2 ratio &gt; 200,

          6. Positive end-expiratory pressure (PEEP) ≤ 5 cm H2O,

          7. Rapid and shallow ratio of frequency to tidal volume (f/VT ≤ 105),

          8. Minute ventilation ≤ 15 L/min, and

          9. pH ≥ 7.3. Supplemental oxygen was continued to maintain an oxygen saturation &gt; 95% as
             measured by a pulse oximeter.

        Exclusion Criteria:

          1. A history of extubation during the same hospitalization

          2. Administration of corticosteroids seven days prior to extubation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chao-Hsien Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mackay Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chao-Hsien Lee, MD</last_name>
    <phone>+886-2-23926589</phone>
    <email>L49428@ms2.mmh.org.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>No. 92, SEC. 2, CHUNG SHAN N. RD, TAIPEI, TAIWAN.</name>
      <address>
        <city>Taipei</city>
        <zip>104</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chao-Hsien Lee, MD</last_name>
      <phone>886-2-23926589</phone>
      <email>L49428@ms2.mmh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Lee CH, Peng MJ, Wu CL. Dexamethasone to prevent postextubation airway obstruction in adults: a prospective, randomized, double-blind, placebo-controlled study. Crit Care. 2007;11(4):R72.</citation>
    <PMID>17605780</PMID>
  </reference>
  <reference>
    <citation>Cheng KC, Hou CC, Huang HC, Lin SC, Zhang H. Intravenous injection of methylprednisolone reduces the incidence of postextubation stridor in intensive care unit patients. Crit Care Med. 2006 May;34(5):1345-50. Erratum in: Crit Care Med. 2007 May;35(5):1454.</citation>
    <PMID>16540947</PMID>
  </reference>
  <reference>
    <citation>François B, Bellissant E, Gissot V, Desachy A, Normand S, Boulain T, Brenet O, Preux PM, Vignon P; Association des Réanimateurs du Centre-Ouest (ARCO). 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet. 2007 Mar 31;369(9567):1083-9.</citation>
    <PMID>17398307</PMID>
  </reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2007</study_first_submitted>
  <study_first_submitted_qc>October 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2007</study_first_posted>
  <last_update_submitted>May 27, 2008</last_update_submitted>
  <last_update_submitted_qc>May 27, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2008</last_update_posted>
  <responsible_party>
    <name_title>Chao-Hsien, Lee</name_title>
    <organization>Mackay memorial hospital</organization>
  </responsible_party>
  <keyword>Endotracheal intubation</keyword>
  <keyword>Laryngeal edema</keyword>
  <keyword>Cuff-leak test</keyword>
  <keyword>Corticosteroids</keyword>
  <keyword>This study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.</keyword>
  <keyword>This study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Airway Obstruction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

